Investec Bank plc has filed a Form 8.5 regulatory disclosure revealing significant trading activity in Advanced Medical Solutions Group Plc (AMS.L) ordinary shares.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank plc acted in a client-serving capacity during the dealings, with the bank serving as Advisor and Joint Broker to Advanced Medical Solutions Group plc.
The transactions were undertaken on 26th June 2026, with the formal public disclosure submitted on 29th June 2026.
On the purchase side, Investec Bank acquired a total of 1,705,802 ordinary shares, with prices ranging from a low of 278 pence to a high of 279 pence per unit.
On the sales side, the bank disposed of a larger position totalling 2,238,448 ordinary shares, with prices ranging between 278.25 pence and 280.5 pence per unit.
The volume of shares sold exceeded the volume purchased during the session, indicating a net reduction in the position handled by Investec in a client-serving capacity.
No cash-settled derivative transactions, stock-settled derivatives, or options activity was reported as part of this disclosure filing.
Investec confirmed there were no indemnity arrangements, option agreements, or other understandings that could serve as an inducement to deal or refrain from dealing with any party to the offer.
The bank also confirmed no agreements or understandings exist relating to voting rights or future acquisition and disposal of relevant securities to which any derivative is referenced.
The contact named on the disclosure is Abhishek Gawde, reachable by telephone at +91-9923757332, as listed in the official regulatory filing submitted to the Regulatory Information Service.
